Flow Matters

Published evidence continues to published almost weekly demonstrating the contribution of Nasal High Flow to improved patient care and outcomes.
Flow Matters is designed to keep health professionals up to date with emerging clinical evidence and practice.


Nasal High Flow publications by year

Search query: nasal high flow
(as of 25th Jan 2021)

Registered clinical trials

478 trials registered against the search term nasal high flow
(as of 15th Jan 2021)

Flow Matters

Edition 11 (August 2020)

What systems and settings are used in NHF research?
Surveys of the studies comprising the body of NHF evidence found the majority used F&P Optiflow systems and flow settings between 45 and 60 L/min.

PDF Read online


LinkedIn  Twitter

Edition 10

NHF is recognized by the
WHO for treatment of patients with

Read about this and research
related to airborne transmission.
PDF Read online


LinkedIn Twitter



Edition 9

A bedside tool for
monitoring patients on NHF.

The validated ROX index uses just 3
data points to provide an indicator
of outcomes in adults with AHRF
receiving NHF therapy.

Stanislav Taktov, M.C., Ph.D.
PDF Read online


LinkedIn Twitter


Edition 8

Featured study, Ischaki et al. 2018.
First published clinical protocol 
detailing the application of High
Flow therapy for adult patients with
acute hypoxemic respiratory failure.



Flow Matters on LinkedIn

Follow us on LinkedIn to be notified as soon as as new edition of Flow Matters is available.

Flow Matters by email

Sign up here to get Flow Matters straight to your inbox as soon as a new edition is available.


Optiflow Nasal High Flow



If you have an enquiry about our products, please provide the following information so a Fisher & Paykel Healthcare representative can contact you. For further details on how this information will be used, see below or go to our privacy statement.





Select your country of residence

Enter security code
 Security code
By submitting this form, you consent to Fisher & Paykel Healthcare storing your personal information to contact you about your enquiry. Your information will be collected and stored securely by Fisher & Paykel Healthcare Limited based in New Zealand and may be shared with the wider Fisher & Paykel Healthcare group as necessary to support your enquiry. We will not share, disclose or sell your information to third parties for marketing purposes. For full details on how we use and manage your personal information, how long we may retain this information for sales or marketing purposes, your rights to access, correct or delete your personal information, and how to contact us about your personal information, please see our privacy statement.


Want to receive updates?

Sign up to receive email notifications of the latest product and therapy information as well as upcoming events.

Sign up here

The outbreak of COVID-19 has impacted healthcare organizations around the world

A resource center has been created to provide affected hospitals and healthcare professionals with information they may need to treat patients when using Fisher & Paykel Healthcare products.

View resource center